Operators more often chose transfemoral over transradial PCI in a patients with higher predicted bleeding risks, despite evidence of fewer bleeding complications with the latter approach. Transfemoral PCI patients also tended to be sicker, according to this observational study.

Are Riata concerns a thing of the past and transcatheter aortic valve replacement (TAVR) for almost anyone with severe aortic stenosis the way of the future? Presentations at recent cardiology conferences addressed those questions.

An analysis of U.S. adults older than 50 found that people with high depressive symptoms during consecutive interviews during a two-year period were twice as likely to have a stroke compared with those who had no or few depressive symptoms.

Patients with implantable cardioverter-defibrillators (ICDs) or cardiac resynchronization therapy (CRT) devices who were most active had improved health outcomes and were more likely to survive, according to a registry analysis.

Sometimes a finding doesn’t reach the bar for statistical significance, but that doesn’t mean it isn’t intriguing. Interventional cardiologists might take note of a study on informed decision making that showed them more likely to touch on key elements than general cardiologists.

Edwards Lifesciences put enrollment into a program using its FORTIS transcatheter valve replacement therapy on hold, announcing that it wants to investigate reports of valve thrombus.

Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery in low-risk patients with severe aortic stenosis, based on two-year results presented May 19 at EuroPCR in Paris.

An analysis of a national registry found there were wide variations in care for patients undergoing carotid artery stenting (CAS) at U.S. hospitals. Based on the researchers’ model, outcomes varied fourfold among hospitals and odds of experiencing a stroke or dying varied by 50 percent for two randomly selected hospitals treating the same patient.